Actively Recruiting
Study of Safety, Tolerability, and Pharmacokinetics of Grammidin With Anesthetic Topical Spray Compared to Lozenges in Healthy Adults Ages 18 to 45
Led by Valenta Pharm JSC · Updated on 2025-07-10
24
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, tolerability, and how the body processes two forms of Grammidin with anesthetic in healthy adults aged 18 to 45. This study compares a metered dose topical spray to lozenges after a single dose to understand their pharmacokinetics and side effects. The trial is sponsored by Valenta Pharm JSC and is a Phase 1 interventional study involving healthy volunteers. Participants receive either the Grammidin with anesthetic neo lozenge, taken once with food, or the Grammidin with anesthetic topical spray, consisting of four sprays taken once with food. The study uses a randomized design where volunteers receive both treatments in different sequences with a washout period between them. The treatments are evaluated in two sequences one starting with lozenges followed by spray, and the other with spray followed by lozenges. Volunteers take part in the study for approximately 15 days, including screening before the study and follow-up visits. During the study, researchers monitor pharmacokinetic parameters such as peak drug concentration and elimination rates over 24 hours after each dose. Safety is closely observed through physical exams, vital signs, ECGs, blood and urine tests, and recording any adverse events. Researchers also track volunteer complaints and overall tolerability during this period.
CONDITIONS
Brief Title
Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here